scholarly journals Biphasic Insulin Aspart 30 Three Times Daily Is More Effective Than a Twice-Daily Regimen, Without Increasing Hypoglycemia, in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetes Drugs

Diabetes Care ◽  
2008 ◽  
Vol 31 (5) ◽  
pp. 852-856 ◽  
Author(s):  
W. Yang ◽  
Q. Ji ◽  
D. Zhu ◽  
J. Yang ◽  
L. Chen ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Aspart ◽  
Daily Regimen ◽  
Biphasic Insulin Aspart ◽  
Biphasic Insulin ◽  
Biphasic Insulin Aspart 30 ◽  
Oral Antidiabetes Drugs ◽  
Chinese Subjects

scholarly journals Comparison of Insulin Degludec/Insulin Aspart and Biphasic Insulin Aspart 30 in Uncontrolled, Insulin-Treated Type 2 Diabetes: A Phase 3a, Randomized, Treat-to-Target Trial

Diabetes Care ◽  
2014 ◽  
Vol 37 (8) ◽  
pp. 2084-2090 ◽  
Author(s):  
Gregory R. Fulcher ◽  
Jens Sandahl Christiansen ◽  
Ganapathi Bantwal ◽  
Miroslawa Polaszewska-Muszynska ◽  
Henriette Mersebach ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Aspart ◽  
Insulin Degludec ◽  
Treat To Target ◽  
Target Trial ◽  
Biphasic Insulin Aspart ◽  
Biphasic Insulin ◽  
Biphasic Insulin Aspart 30

Therapy conversion to biphasic insulin aspart 30 improves long-term outcomes and reduces the costs of type 2 diabetes in Saudi Arabia

2008 ◽  
Vol 11 (4) ◽  
pp. 651-670 ◽  
Author(s):  
Mohammed Ali ◽  
Jeremy White ◽  
Chen-Hui Lee ◽  
James L Palmer ◽  
Jayne Smith-Palmer ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Saudi Arabia ◽  
Insulin Aspart ◽  
Long Term Outcomes ◽  
Biphasic Insulin Aspart ◽  
Biphasic Insulin ◽  
Biphasic Insulin Aspart 30
Sign in / Sign up

Export Citation Format

Share Document